Cheryl Jalfon
Emergency Medicine · Houston, TXNPI 1013952076
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 56 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 38 manufacturers, the largest accounting for just 10.7% — the pattern of someone who eats at a lot of different presentations. Among emergency medicine clinicians in TX with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 56 payments — averaging $108.20 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$648
- Abbott$474
- Gilead$351
- Regeneron Healthcare Solutions, Inc.$343
- Sanofi$334
- Amgen$266
- plus $4K from 32 others
What the payments were for
- Food & beverage$6,059100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca(2 entities) | 6 | $648 |
| Abbott | 4 | $474 |
| Gilead | 3 | $351 |
| Regeneron Healthcare Solutions, Inc. | 3 | $343 |
| Sanofi | 3 | $334 |
| Amgen | 2 | $266 |
| Kyowa Kirin, Inc. | 2 | $244 |
| Xeris Pharmaceuticals, Inc. | 2 | $229 |
| Mallinckrodt Hospital Products Inc. | 1 | $138 |
| Lucid Diagnostics Inc. | 1 | $138 |
| Abiomed | 1 | $126 |
| Intercept Pharmaceuticals, Inc. | 1 | $125 |
| AbbVie | 1 | $125 |
| Phathom Pharmaceuticals, Inc. | 1 | $123 |
| Otsuka America Pharmaceutical, Inc. | 1 | $122 |
| Ascendis Pharma Endocrinology Inc | 1 | $122 |
| Alnylam Pharmaceuticals Inc. | 1 | $122 |
| Stemline Therapeutics Inc. | 1 | $122 |
| Jazz Pharmaceuticals Inc. | 1 | $122 |
| Esperion Therapeutics, Inc. | 1 | $119 |
| Inspire Medical Systems, Inc. | 1 | $119 |
| BTG International Inc. | 1 | $118 |
| Acadia Pharmaceuticals Inc | 1 | $118 |
| Sanofi-aventis U.S. LLC | 1 | $116 |
| Y-mabs Therapeutics, Inc. | 1 | $113 |
| Neurocrine Biosciences, Inc. | 1 | $110 |
| Edwards Lifesciences | 1 | $101 |
| Otsuka Pharmaceutical Development & Commercialization, Inc. | 1 | $100 |
| Alk-abello, Inc | 1 | $99 |
| GSK | 1 | $99 |
| Pharming Healthcare, Inc. | 1 | $97 |
| Vertex | 1 | $96 |
| Eisai Inc. | 1 | $84 |
| Molnlycke Health Care US, LLC | 1 | $77 |
| Biogen | 1 | $69 |
| Lundbeck LLC | 1 | $60 |
| Coloplast | 2 | $54 |
| Medtronic | 1 | $38 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$6,059 in reported general payments places this provider in the 95th percentile of 3,952 emergency medicine providers in Texas.
Other emergency medicine in Houston
- William PeacockHouston$513K
- David RobinsonHouston$143K
- Basil KhalafHouston$93K
- Yen-Te TuHouston$60K
- Zubaid RafiqueHouston$52K
- Kelly LarkinHouston$48K
- Amanda HumphriesHouston$28K
- Bentley BobrowHouston$27K
- Samuel PraterHouston$22K
- Cedric DarkHouston$20K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.